Notice ID: 560f207b999a4f18a4640634c348fe14Combined Synopsis/Solicitation
Transportation Services for Impaired Employees
Archived on September 25, 2024. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 11:00 AM UTC−04:00
- Posted
- September 5, 2024
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- Small Business Set Aside - Total
- NAICS
- 485320: Limousine Service
- Agency
- Department of Health and Human ServicesCENTERS FOR MEDICARE AND MEDICAID SERVICES
Notice details
- Office
- OFFICE OF ACQUISITION GRANTS MGMT
- Place of performance
- Windsor Mill, 21244
- Last updated
- Sep 25, 2026
Identifiers
- Solicitation number
- OEOCR-393-2024-0018-RAW
- Notice ID
- 560f207b999a4f18a4640634c348fe14
Description
This is a Request for Quotation prepared in accordance with FAR Part 13, as supplemented with additional information included with this notice. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION: A SEPAATE WRITTEN SOLICITATION WILL NOT BE ISSUED. QUOTES ARE BEING REQUESTED. The Centers for Medicare and Medicaid Services (CMS) intends to award on a competitive basis, under the Simplified Acquisition Procedures in accordance with the attached FAR Part 13, a fixed priced award to provide Transportation Services to employees with visual or impaired mobility to conferences, trainings, forums, etc. without barriers in accordance with the attached Statement of Work and technical evaluation criteria. The purchase order resulting from this RFQ will be awarded to the responsible Offeror whose quote, confirming to the solicitation, is determined to be the “Best Value to the government. CMS reserves the right to award based upon the initial quote; therefore, the initial quote should contain the Offeror’s best terms. CMS also reserves the right to conduct exchanges with fewer than all Offerors. All responsible sources must be registered at www.sam.gov. The period of performance is for 12 months from date of award with 2 option years. The North American Industry Classification System Code (NAICS) is 561621 Security System Services. Responses must be sent electronically in MS Word format to renee.wallaceabney@cms.hhs.gov no later than 11:00 a.m. (EST) on September 10, 2024. All questions should be submitted electronically 11:00 AM (EST) on September 2, 2024. Questions will not be answered by telephone. All responses/quotes submitted shall be remain valid for a period of 180 days. Interested parties must be able to affirm no conflicts of interest with parties involved in Medicare claims processing considering the work identified in this Statement of Work. If the vendor/government identifies a conflict or the appearance of a conflict, the vendor shall be responsible for providing a mitigation strategy that satisfies the government. If the conflict cannot be resolved, the order cannot be awarded, or an existing order may need to be terminated MS reserves the right to award based upon the initial quote
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
No documents available.
Lifecycle
Solicitation:
OEOCR-393-2024-0018-RAW- Combined Synopsis
- 2×Combined SynopsisCurrentAug 27, 2024
Transportation Services for Impaired Employees
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The Embassy of the United States in Paris, France, anticipates issuing a solicitation for Passenger Transportation Services with Chauffeured Motor Vehicles (4-pax Sedan and 7-pax Minivan Vehicles) in Paris and its vicinity for the U.S. Mission in Paris, France. Interested companies must have the capacity to provide between twenty (20) to seventy (70) Chauffeured Motor Vehicles. Please note this solicitation is not ready yet. The Embassy of the United States in Paris, France will upload this solicitation on the SAM website when it is available. The Government intends to award the contract resulting from this solicitation to the lowest priced technically acceptable offeror who is a responsible contractor. The Government may award the contract based on the initial offer without discussion. The resultant contract will be an IDIQ (indefinite delivery indefinite quantity) contract under which task orders will be issued. The contract will be for one base year and four one-year options. Post may implement multiple awards to multiple vendors for these services. All contractors must be registered in the SAM (System for Award Management) Database https://www.sam.gov prior to submitting an offer pursuant to FAR provision 52.204-7. Therefore, prospective offerors are encouraged to register at the earliest stage. The guidelines for registration in SAM are also available at: https://www.fsd.gov/fsd-gov/learning-center-system.do?sysparm_system=SAM This is a pre-solicitation notice only. No proposals or quotes are being requested or accepted at this time. | - | Pre-Solicitation | Open |
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFP, if issued. The purpose of this sources sought synopsis is to gain knowledge of potential qualified vendors to include potential 8(a) vendors 8(a) relative to the North American Industry Classification System (NAICS) code and capable of providing multidisciplinary scientific and regulatory professional services in support of FDA Centers and Offices. Responses to this Sources Sought Notice will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA Scientific and Regulatory Support Services (SRS) IDIQ Background/Overview: The Food and Drug Administration (FDA) is a science-based regulatory agency critically important to the stability of the nation's public health and health care systems. FDA protects and promotes the health and safety of all Americans by enhancing the availability of safe medical products, foods, and animal products, and by promoting innovation that addresses unmet medical and public health needs. FDA decisions must be based on the best available scientific data and employ the best tools and methods available to ensure products meet the highest quality standards, while fostering innovation in the products it regulates. In support of its regulatory mission, FDA conducts scientific research across a broad range of disciplines including vaccines, drug safety, food safety, medical devices, biologics, toxicology, radiological products, and more. FDA's science is increasingly data-centric, complex, and collaborative, involving multidisciplinary groups across its Centers and Offices. Within the Center for Drug Evaluation and Research (CDER), the Office of Computational Science (OCS), established under the Office of Translational Sciences, supports the data management, technical, and analytic needs of the regulatory review process. OCS manages and supports analytical tools, data standards, and computing infrastructure that form the backbone of modern regulatory review for medical products. Purpose: The FDA is seeking information from experienced sources in Scientific and Regulatory Support Services as it is contemplating the establishment of a Indefinite Delivery Indefinite Quantity (IDIQ) to such services. The FDA’s primary objective for this effect is to obtain Contractor services related to scientific and regulatory support across a broad range of mission requirements. Depending on the requirement, services may support scientific research, regulatory review, clinical and non-clinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. Objectives: The objective of the contemplated SRS acquisition is to provide FDA with responsive, high-quality scientific and regulatory support across a broad range of mission requirements. Depending on the task order, services may support scientific research, regulatory review, clinical and nonclinical analyses, epidemiology and surveillance, scientific data interpretation, laboratory activities, technical writing, training, and scientific program coordination. The Government is interested in sources capable of providing the scientific depth and operational capacity needed to: Conduct scientifically sound analyses and prepare defensible, traceable technical products supporting FDA review and public-health decisions. Provide qualified personnel across multiple scientific and regulatory disciplines, including specialized and emerging areas. Support clinical and nonclinical study-data review, standardized scientific datasets, statistical computing, data fitness, quality assessment, and interpretation. Respond to multiple simultaneous task orders, changing priorities, time-sensitive scientific questions, and evolving requirements across FDA organizations. Maintain scientific quality, data integrity, documentation, confidentiality, and continuity of performance. Deliver effective scientific training, technical writing, knowledge transfer, and program-management support tied directly to scientific and regulatory missions. Project Requirements: The following descriptions are illustrative of the types of services that may be ordered. They are provided to inform industry responses and do not establish final task-order requirements. Each task order would define its own objectives, tasks, deliverables, performance expectations, staffing qualifications, and period of performance. Scientific Research and Regulatory Review Support: Support scientific investigations, literature and evidence reviews, research planning, study design, methodological assessments, scientific consultations, and technical analyses relevant to FDA-regulated products. Prepare scientific assessments, briefing materials, review support documentation, and other products that allow Government scientists and reviewers to evaluate scientific evidence and communicate findings. Provide subject-matter expertise to address complex or emerging regulatory science questions. Clinical and Nonclinical Study-Data Review and Analysis: Support the scientific review of clinical and nonclinical datasets submitted for regulatory purposes, including data fitness and completeness assessments, exploratory safety analyses, descriptive and inferential statistical analyses, and preparation of tables, listings, figures, and visualizations. Subject-matter expertise in applicable clinical and nonclinical study-data standards, including CDISC SDTM, ADaM, and SEND, is particularly relevant to these services. The RRS BPA describes review-oriented services that assess study data and produce analyses for FDA reviewers; SRS would focus on the scientific and analytical performance of those services rather than maintenance of the underlying software platforms. Epidemiology, Biostatistics, Pharmacovigilance, and Surveillance: Conduct epidemiological and Pharmacoepidemiological research, biostatistical analyses, pharmacovigilance assessments, signal detection and evaluation, public-health surveillance, and interpretation of real-world data and evidence as required by individual scientific programs. Activities may include protocol and analysis-plan support, assessment of study limitations and bias, statistical programming, results interpretation, and technical reporting. Scientific Data Standards, Quality, and Analytics: Provide scientific expertise related to data standards, controlled terminology, study-data interpretation, data quality and fitness, and reproducible analytical methods. Support scientific data preparation and validation, biostatistics, bioinformatics, computational science, and other specialized analyses when the primary deliverable is scientific or regulatory in nature. Distinguish these activities from enterprise database administration, application development, platform engineering, and IT operations. Laboratory and Specialized Scientific Support: Provide laboratory-related scientific and technical expertise, research assistance, analytical method support, study coordination, quality documentation, and interpretation or reporting of laboratory findings where required by a task order. Respondents should identify the specific laboratory disciplines, facilities, qualifications, and methods they can support rather than assume that all clinical trial operations or laboratory testing will be included. Scientific Writing, Training, Knowledge Management, and Communications: Develop scientific reports, regulatory review support materials, technical summaries, study documentation, research publications, presentations, training curricula, and knowledge-transfer materials. Provide specialized scientific and regulatory training, including instruction related to study-data standards and analytical methods. Communications and knowledge-management work should be directly connected to scientific or regulatory activities rather than general enterprise communications or IT support. Scientific Program and Project Management: Plan and coordinate scientific studies and projects; manage milestones, deliverables, schedules, staffing, and technical reporting; facilitate multidisciplinary collaboration; track performance and quality; and support continuity during transitions. Such activities must be integral to scientific and regulatory service delivery, not standalone enterprise IT project management. Scope Distinctions: The contemplated SRS acquisition is not intended to replace vehicles for enterprise IT architecture, systems or application development, cloud or data-platform operations, infrastructure administration, software maintenance, generalized service-desk support, or other predominantly IT functions. Where a task combines scientific analysis and enabling technology, the Government will determine the appropriate vehicle and scope based on the primary purpose of the requirement. The final boundary between SRS and remaining RRS or other vehicles is subject to FDA and OAGS confirmation. Capabilities and Technical Experience: Interested small businesses should submit a concise capability statement demonstrating relevant, actual performance and capacity to satisfy the contemplated requirements. Responses should clearly distinguish capabilities performed by the respondent from those provided by subcontractors, affiliates, or proposed teaming partners. FDA is particularly interested in the following: Relevant Experience: Describe comparable scientific and regulatory engagements, customer organizations, contract or order identifiers where releasable, approximate value, period of performance, work performed, disciplines supported, and measurable outcomes. Explain how the experience relates to the breadth and complexity of the contemplated SRS work. Scientific and Regulatory Disciplines: Describe the service areas the respondent can perform, with concrete examples involving scientific research, regulatory analysis, clinical and nonclinical datasets, statistical methods, epidemiology, laboratory work, scientific writing, and training as applicable. Do not claim disciplines for which experience cannot be substantiated. Workforce and Concurrent Delivery Capacity: Describe the organization's demonstrated ability to recruit, retain, and deploy highly specialized scientific and regulatory professionals across a broad range of disciplines, including individuals with advanced degrees, niche technical expertise, and experience supporting complex scientific and regulatory programs. FDA recognizes that certain highly specialized skill sets may require recruitment from an international talent pool, including individuals holding or requiring employment-based visa sponsorship (e.g., H-1B) or other appropriate work authorization. Respondents should describe their experience recruiting and retaining such personnel, managing applicable sponsorship and work authorization requirements, and mitigating potential staffing disruptions during contract transitions. Responses should also address the organization's ability to fill hard-to-recruit positions, maintain continuity of specialized expertise, accommodate surge requirements, and support multiple concurrent task orders. Where available, provide representative workforce metrics, such as available staffing capacity, average time-to-fill for specialized positions, and retention or attrition trends. Include a representative example demonstrating the organization's ability to respond to surge requirements or manage concurrent scientific and regulatory assignments, including its approach to staffing continuity, resource allocation, and timely delivery. Scientific Quality and Data Practices: Describe scientific quality-control procedures, independent review, data integrity and reproducibility practices, use of applicable scientific standards, confidentiality controls, and experience handling sensitive regulatory or research information. Representative Complex Requirement: Describe one or more specific scientific or regulatory assignments presenting substantial technical complexity, urgent timelines, multidisciplinary coordination, or simultaneous delivery requirements. Explain the challenge, approach, expertise, staffing considerations, deliverables, and outcomes. AI, Emerging Technology, and Responsible Use: Describe the organization's experience applying artificial intelligence (AI), machine learning (ML), or other emerging technologies to scientific research, regulatory review, or related analytical activities, as applicable. Provide representative examples of these applications and describe the organization's approaches to validating outputs, maintaining scientific integrity, ensuring appropriate human oversight, and managing associated risks. Identify any experience implementing responsible AI practices or governance frameworks, particularly in federal or regulated environments. Teaming and Prime-Contractor Role: Describe anticipated prime, subcontracting, joint-venture, or teaming arrangements and the work each participant would perform. Explain how the prime would exercise management and technical oversight while meeting applicable small-business requirements. Contract Structure Feedback: Identify whether the firm could support the full breadth of contemplated services or a defined subset and explain why. Instructions for Responses: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions). The anticipated period of performance is a 5-year ordering period. After review of the responses received, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). Responses to this notice must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Is your firm certified under Section 8(a) of the Small Business Act? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (Attachment A). All interested parties can provide written opinions on the draft Statement of Work. All opinions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Business Status Provide the legal business name and address Primary point of contact and the contact information SAM.gov Unique Entity Identifier (UEI) CAGE code Proposed NAICS code and size status Applicable small-business socioeconomic designations (including 8(a), HUBZone, service-disabled veteran-owned, veteran-owned, women-owned, or small disadvantaged business, as applicable) Identify whether the respondent proposes to participate as prime contractor, joint venture, or subcontractor Responses to this notice shall be submitted via e-mail to Amanda Edger, Contract Specialist, at Amanda.Edger@fda.hhs.gov (with a CC: to Ian Weiss, Contracting Officer, at Ian.Weiss@fda.hhs.gov), by November 23, 2026, at 2:00 pm EST. After a review of the received responses, a pre-solicitation synopsis and formal solicitation may be published on SAM.gov. No solicitation is currently available. This is not a request for proposals and in no way obligates the Government to award any contract. Responses to this Sources Sought Notice will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Ref. No. FDA-RFI-75F40127R00007/ALP No. OMITS-2027-136942. | - | Market Research | 11/23/2026 |
AMENDMENT 1 REVIEW AMENDMENT AND UPDATED ATTACHMENTS COMBINED SYNOPSIS / SOLICITATION (COMPETITIVE) Title: 2 Senior Advisors Services for the NINDS Blueprint Neurotherapeutic Network for Small Molecules External Oversight Committee (EOC) Subject Matter Expert (SME) Services (i) This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with RFO Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. The solicitation number is 7571PS27Q00021 issued as a Request for Quote for 2 Senior Advisors Services for the NINDS Blueprint Neurotherapeutic Network for Small Molecules External Oversight Committee (EOC) Subject Matter Expert (SME) Services . The Government reserves the right to make one award, multiple awards, or no awards as a result of this solicitation. This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (ii) This requirement is for the following services: The purpose of this requirement is to procure 2 Senior Advisors [subject matter expert (SME) services in support of NIH Blueprint Neurotherapeutics Network drug discovery and development programs and the associated BPN External Oversight Committee. (iii) Description of requirement: The NIH is seeking to procure a highly experienced executive-level, drug discovery and development 2 Senior Advisors with experience in the area of Chemistry and/or Pharmacology to provide feedback to the NIH program leadership and technical guidance on drug discovery and development projects within the BPN portfolio. The Contractor will serve as a member of the BPN External Oversight Committee, which provides strategic guidance on BPN projects and on occasion other NIH drug discovery and development programs. See Attachment #1 - Statement of Work (SOW) for more information. (iv) The Government anticipates award of a Fixed Price purchase order for this acquisition, and the anticipated base period of performance is: Base: 11/5/2026 – 11/4/2027 Option Year 1: 11/5/2027 – 11/4/2028 Option Year 2: 11/5/2028 – 11/4/2029 (v) The provisions at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this address: https://www.acquisition.gov/far-overhaul https://www.hhs.gov/contract-policies-regulations/hhsar-overhaul (End of provision) The following FAR provisions are required by FAR 12.2025(a), and incorporated by reference: FAR 52.212-1 (Nov 2025) (RFO Deviation), Instructions to Offerors-Commercial Products and Commercial Services. The following FAR provisions are required as applicable to this requirement and incorporated by reference: See Attachment 2 for (Table # 12-2) under FAR 12.205 (a)(3). The following HHSAR provisions are applicable to this requirement and incorporated by reference (available upon request): HHSAR 352.239.78 – Information and Communication Technology Accessibility Notice (FEB 2024) (Deviation) (vi) The clauses at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: https://www.acquisition.gov/far-overhaul https://www.hhs.gov/contract-policies-regulations/hhsar-overhaul (End of clause) The following FAR clauses are required by FAR 12.205(b)(1) for all solicitations and incorporated by reference: FAR 52.212-4 (Nov 2025) (RFO Deviation), Terms and Conditions—Commercial Products and Commercial Services. The following FAR clauses are required as applicable to this requirement and incorporated by reference: See Attachment 3: Table# 12-3. FAR 52.232-39, Unenforceability of Unauthorized Obligations (Jun 2013). The following HHSAR clauses are applicable to this requirement and incorporated by reference: HHSAR 352.204-71, Information and Information System Security (FEB 2024) (Deviation). HSHAR 352-204-73 – Contractor Personnel Security and Agency Access (FEB 2024) (Deviation). HHSAR 352-239-79 – Information and Communication Technology Accessibility (Feb 2024) (Deviation). FAR/HHSAR PROVISIONS/CLAUSES – FULL TEXT-ADDITIONAL TERMS AND CONDITIONS The following provisions/clauses and additional terms and conditions apply to this acquisition and are provided in FULL TEXT: HHSAR 352-237-75 Key Personnel (Oct 2026) (RFO Deviation) - Key personnel specified in this contract are essential to work performance under the contract. The Contractor must obtain the written consent of the Contracting Officer prior to diverting, replacing, or announcing any key personnel substitutions. At least 30 days prior to the Contractor voluntarily diverting any of the specified individuals to other programs or contracts, the Contractor must submit requests for changes in key personnel to the Contracting Officer in writing. The request must identify the circumstances, proposed replacement, a resume and explanation of how the replacement's skills, experience, and credentials meet or exceed the requirements of the contract. When advance notice is not practicable because of termination for cause, other voluntary separation or another circumstance outside the Contractor’s reasonable control, the Contractor must notify the Contracting Officer as soon as practicable. (End of clause) FAR 52.217-7, Option for Increased Quantity-Separately Priced Line Item (Mar 1989) The Government may require the delivery of the numbered line item, identified in the Schedule as an option item, in the quantity and at the price stated in the Schedule. The Contracting Officer may exercise the option by written notice to the Contractor within the period of performance of the contract. Delivery of added items shall continue at the same rate that like items are called for under the contract, unless the parties otherwise agree. (End of clause) c) 52.217-9 Option to Extend the Term of the Contract. (a) The Government may extend the term of this contract by written notice to the Contractor within 15 days of contract expiration; provided that the Government gives the Contractor a preliminary written notice of its intent to extend within the period of performance of the contract. The preliminary notice does not commit the Government to an extension. (b) If the Government exercises this option, the extended contract shall be considered to include this option clause. (c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed 3 years. (End of clause) TECHNICAL EVALUATION AND INSTRUCTIONS The Government will evaluate quotations or offers in accordance with RFO FAR 12.203 and award a purchase order from this solicitation to the responsible vendor whose quote conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The factors included in Attachment 5 – Evaluation Factor--shall be used to evaluate quotes: a) Technical capability of the item offered to meet the Government requirement; b) Price; and c) Past performance [see RFO FAR 12.203(a)(2)]. Technical Requirements Instructions: Responses must include clear and convincing evidence of the Quoter’s capability of fulfilling the requirement as it relates to Technical Factor 1: Personnel Qualifications. These responses shall include resumes of proposed key personnel, consultants, and any subcontractors, as well as a letter of commitment from proposed key personnel. These responses should also clearly identify whether proposed personnel will be or are an employee of the Quoter. Please note that all proposed key personnel must be employed by the Quoter no later than the start of the contract’s period of performance. Please note, however, that while resumes of all proposed key personnel are required, they are NOT, by themselves, sufficient. Quoters MUST also submit a separate narrative demonstrating how proposed Key Personnel satisfy the Personnel Qualifications evaluation criteria. Please carefully examine the evaluation criteria prior to writing this narrative. Business Instructions: Quoters are required to complete Attachment 4 – Price Template. Quoters are only to fill in the highlighted cells (including the proposed labor rate and the number of consultants being proposed); all other cells will then auto-populate. Quoters must submit the completed pricing template in Excel (do not convert to PDF) as a separate attachment and shall not combine or embed the pricing template with other materials. Quoters will note that the Government anticipates estimated 50 labor hours per year, with an option for an up-to-additional 50 hours per year. It should also be noted that the Government may reimburse the successful Quoter(s) for up to $2,000 in annual travel-related expenses, per-consultant, that are necessary for performance of this requirement. These funds shall be provided only after it is determined there is a need for travel. Additionally, all travel requests require advance approval by the Government. If the Quoter proposes the involvement of any additional staff besides the Key Personnel, it must clearly articulate their role and why it believes additional personnel are necessary to fulfill the requirement. The Quoter must also specify how this time will be charged (e.g. direct hourly rate or included within overhead). Finally, the Quoter is required to document its rationale for any proposed Other Direct Costs (ODCs) besides travel as well as the total amount. If any of these conditions are applicable, the Quoter shall add rows for the additional costs to the Price Template and include a Price Narrative in its response. Salary Rate Limitation: Quoters are advised that no NIH funds may be used to pay the direct annual salary of an individual through any contract awarded as a result of this solicitation at a rate in excess of the Executive Schedule, Level II* (direct salary is exclusive of Overhead, Fringe Benefits and General and Administrative expenses, also referred to as "indirect cost" or "facilities and administrative (F&A) costs"). Direct salary has the same meaning as the term "institutional base salary." An individual's direct salary (or institutional base salary) is the annual compensation that the Quoter pays for an individual's appointment whether that individual's time is spent on research, teaching, patient care or other activities. Direct salary (or institutional base salary) excludes any income that an individual may be permitted to earn outside of duties to the Quoter. This does not preclude Quoters from absorbing that portion of an employee's annual salary (plus the dollar amount for fringe benefits and associated indirect costs) that exceeds a rate of the Executive Schedule, Level II*. The Executive Schedule, Level II* annual salary rate limitation also applies to individuals proposed under subcontracts as well as consultants. LINK TO EXECUTIVE SCHEDULE RATES OF PAY: https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/ (For current year rates, click on Salaries and Wages/Executive Schedule/Rates of Pay for the Executive Schedule. For prior year rates, click on Salaries and Wages/select Another Year at the top of the page/Executive Schedule/Rates of Pay for the Executive Schedule. Rates are effective January 1 of each calendar year unless otherwise noted.) Past Performance: Quoter shall identify 1-2 awards with the Federal Government and/or commercial customers that demonstrate recent and relevant past performance. Relevant is defined as work similar in complexity and magnitude to the work described in the SOW. Quoter shall include the following information in their past performance examples: Project title Description of the project Contract number Contract amount Government Agency/Organization Point of contact name, address, and phone number Contract and, if applicable, task order number Current status, e.g., completed and/or if in progress, start and estimated completion dates SOW paragraphs that the reference applies to Key personnel (please highlight those individuals who worked on the relevant project(s) and are also being proposed for this effort.) A brief narrative of why you deem the reference to be relevant to this effort Response Format: Quoter responses shall be no more than ten (10) single-sided pages in length. This page limit includes the following: Cover Page, if applicable Executive Summary, if applicable Table of Contents, if applicable Key Personnel Narrative (no more than two pages) Price Narrative, if applicable Past Performance Examples This page limit does NOT include: Key Personnel Resume(s) Letter(s) of Commitment Representations and Certifications Completed Price Template Additional Required Information: In addition to the previously discussed requirements, Quoters must include the following in their response: Company’s Full Name and Address Unique Entity ID (UEI) Name, Telephone Number, and Email Address of Person Authorized to Provide Quote Please note that, to be considered for award, Quoters must also be actively registered in the System for Award Management (SAM), accessible at www.sam.gov, at the time of quote submission. Options - The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. The evaluation of options does not obligate the Government to exercise the option(s). Notice of award. A written notice of award or acceptance of an offer furnished to the successful Offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (End of provision) The following invoice instruction is included and will be incorporated in the final award: Agency Invoicing Instructions (Attachment 6, Invoice Instructions). (vii) Quoter must submit all required materials by 1:00 PM Eastern Time on November 5, 2026 and reference solicitation number 7571PS27Q00021 Responses must be submitted electronically to Ebony Chester and Michelle Cecilia, Contracting Office, at michelle.cecilia@hhs.gov All questions must be received by November 5, 2026, at 1:00 p.m. EST, and reference Solicitation Number 7571PS27Q00021. (viii) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. The associated NAICS code 541690 and the small business size standard is $19 million. FAR DEVIATION STATEMENT: “System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in this solicitation. Contracting officers will rely on representations from offers based on provisions in the solicitation. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM.” Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal/quote must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. The Unique Entity ID (UEI) from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. | - | Combined Synopsis | 11/09/2026 |
See Amendment P001. The Contractor shall provide medical-expert services and medical reviewer/case management support for the National Vaccine Injury Compensation Program (VICP) and the Countermeasures Injury Compensation Program (CICP) in support of the litigation process, including the defense of petitions filed against the Secretary of Health and Human Services (HHS). This solicitation will remain open until August 24, 2026. Quotes will be reviewed, and BPAs may be issued on a rolling basis as quotes are received. The Government anticipates establishing BPAs with qualified vendors during this open period. | - | Solicitation | 08/20/2031 |
Amendment 1 - This amendment provides questions to vendor clarifying questions and adds a revised RFQ (updated per vendor questions) and revised SOW (Task Order 2 updated). All changes to the revised documents are in red text. The goal of this acquisition is to acquire a contractor that offers a full range of (1) clinical research services, including clinical research management, statistical design and analysis, protocol development and data management, clinical site management, pharmacovigilance services, quality assurance, and regulatory affairs support; (2) specialty services, including DSMB services; (3) analytical solutions, including bioinformatics, and (4) integrated clinical trial management through an organized system of tracking clinical trials. The contractor should be capable of providing these services, as required under the individual task orders, to support NHGRI clinical research protocols and related activities within the scope of this IDIQ contract. The contractor should be capable assigning qualified personnel with experience in clinical trial design and regulatory requirements, especially as relates to studies of rare diseases, genetic conditions, gene therapy (including via AAV9 vectors), and pediatric as well as adult populations, as applicable to individual task orders. | - | Combined Synopsis | 11/13/2026 |
Additional Details
Solicitation Number
OEOCR-393-2024-0018-RAW
Archive Date
Sep 25, 2024
Office Address
BALTIMORE, MD, 21244